DGAP-Adhoc: Loewe AG: Potential Loewe investor presents

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-Adhoc: Loewe AG: Potential Loewe investor presents specific offer

Loewe AG / Key word(s): Miscellaneous 28.10.2013 15:17 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Kronach, 28 October 2013. - Loewe is able to announce that it has received an initial specific, written offer from a financial investor that has declared it is prepared to support Loewe's strategic realignment concept in the long term. The offer, which has yet to be finalised and implemented, entail the acquisition of the operative business of the Loewe Group as well as the principal assets of Loewe AG; the investor is not planning to take stakes or acquire Loewe AG itself. Loewe will now assess and evaluate the submitted proposal in detail. The aim is to solve the outstanding points over the next few weeks, and to finalise the necessary contractual documentation. Conclusion of a specific agreement with a new investor represents a crucial building block within the context of the strategic realignment of Loewe. It is also possible that further offers could be received, possibly with other transaction structures. --------------------------------------------------------------------------- Information and Explaination of the Issuer to this News: Contact: Christoph Möller phone: +49 (0)221 80 10 87-87 e-mail: cm@moeller-pr.de 28.10.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Loewe AG Industriestrasse 11 96317 Kronach Germany Phone: +49 (0)9261 99-984 Fax: +49 (0)9261 99-994 E-mail: ir@loewe.de Internet: www.loewe.de ISIN: DE000A1X3W34 WKN: A1X3W3 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading